The Technical Analyst
Intelligent Medicine [IQMD]
Exchange: NASDAQ Sector: Financial Services Industry: Shell Companies
Intelligent Medicine Price, Forecast, Insider, Ratings, Fundamentals & Signals
7.71% $11.04
America/New_York / 4 apr 2024 @ 16:00
| RATING 2023-05-10 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Neutral | |
| Return On Asset: | Strong Buy | |
| DE: | Sell | |
| P/E: | Strong Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/21 | 4/21 | 1/22 | 2/22 | 3/22 | 4/22 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | n/a | |||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 23.00 | sector: PE -18.15 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 23.00 | industry: PE -25.74 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 10.94 - 11.14 ( +/- 0.91%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-04-17 | Goldman Sachs Group Inc | Buy | 0 | Class A Common Stock |
| 2023-04-17 | Goldman Sachs Group Inc | Buy | 1 067 | Equity Swap |
| 2023-02-24 | Saba Capital Management, L.p. | Sell | 2 170 581 | Common Stock |
| 2023-02-08 | Intelligent Medicine Sponsor Llc | Sell | 200 000 | Class B Common Stock |
| 2022-05-05 | Saba Capital Management, L.p. | Buy | 0 | Common Stock |
| INSIDER POWER |
|---|
| -100.00 |
| Last 5 transactions |
| Buy: 0 | Sell: 7 345 581 |
Forecast:
01:40 - $10.70
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $11.04 (7.71% ) |
| Volume | 0.219 mill |
| Avg. Vol. | 0 mill |
| % of Avg. Vol | 0 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For IQMD
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
IQMD
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.
Latest Press Releases
2023-04-26 08:30:00 - Press Release
Intelligent Medicine Acquisition Corp. Announces It Will Redeem Its Public Shares
Bethesda, md.--(business wire)--intelligent medicine acquisition corp. (nasdaq:iqmd) (the “company”), a blank-check company formed for the purpose of acquiring or merging with one or more businesses, today announced that because the company does not believe it will be able to consummate an initial business combination within the time period required by its amended and restated certificate of incorporation (the “charter”), the company intends to dissolve and liquidate in accordance with the provisions of the charter, and will redeem all of the outstanding shares of class a common stock that were included in the units issued in its initial public offering (the “public shares”), at a per-share redemption price of approximately $11...
2023-02-03 17:00:00 - Press Release
Intelligent Medicine Acquisition Corp. Announces Adjournment Of Special Meeting Of Stockholders
Bethesda, md.--(business wire)--intelligent medicine acquisition corp. (nasdaq: iqmd) (the “company”) announced today that it has postponed the company’s special meeting of stockholders to be held on february 3, 2023, at 9:30 a.m. eastern time until february 8, 2023, at 9:30 a.m. eastern time. the postponed special meeting will be completely virtual, and stockholders will be able to attend the special meeting online, vote and submit questions by visiting https://www.cstproxy.com/iqmdspac/2023. there will be no change in the record date as a result of this postponement or the date by which stockholders must have elected to redeem their public shares, and proxies tendered prior to the postponed date will not need to be voted again...